| Literature DB >> 15033588 |
Mark Toraason1, Richard Albertini, Steven Bayard, William Bigbee, Aaron Blair, Paolo Boffetta, Stefano Bonassi, Steven Chanock, David Christiani, David Eastmond, Samuel Hanash, Carol Henry, Fred Kadlubar, Frank Mirer, Daniel Nebert, Stephen Rapport, Kathleen Rest, Nathaniel Rothman, Avima Ruder, Russell Savage, Paul Schulte, Jack Siemiatycki, Peter Shields, Martyn Smith, Paige Tolbert, Roel Vermeulen, Paolo Vineis, Sholom Wacholder, Elizabeth Ward, Michael Waters, Ainsley Weston.
Abstract
As high-throughput technologies in genomics, transcriptomics, and proteomics evolve, questions arise about their use in the assessment of occupational cancers. To address these questions, the National Institute for Occupational Safety and Health, the National Cancer Institute, the National Institute of Environmental Health Sciences, and the American Chemistry Council sponsored a workshop 8-9 May 2002 in Washington, DC. The workshop brought together 80 international specialists whose objective was to identify the means for best exploiting new technologies to enhance methods for laboratory investigation, epidemiologic evaluation, risk assessment, and prevention of occupational cancer. The workshop focused on identifying and interpreting markers for early biologic effect and inherited modifiers of risk.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15033588 PMCID： PMC1241892 DOI： 10.1289/ehp.6343
Source DB: PubMed Journal: Environ Health Perspect ISSN： 0091-6765 Impact factor: 9.031